Eve Health : Update - Proposed issue of securities - EVE

Proposed issue of securities

Update Summary

For personal use only

Entity name

EVE HEALTH GROUP LIMITED.

Announcement Type

Update to previous announcement

Date of this announcement

22/2/2022

Reason for update to a previous announcement

Correcting information in Part 7E of form.

Refer to next page for full details of the announcement

Proposed issue of securities

1 / 6

Proposed issue of securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of +Entity

EVE HEALTH GROUP LIMITED.

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation).

1.2	Registered Number Type	Registration Number
ABN	89106523611
1.3	ASX issuer code
EVE

1.4 The announcement is

Update/amendment to previous announcement

1.4a Reason for update to a previous announcement

Correcting information in Part 7E of form.

1.4b Date of previous announcement to this update

22/2/2022

1.5 Date of this announcement

22/2/2022

1.6 The Proposed issue is:

A placement or other type of issue

Proposed issue of securities

2 / 6

Proposed issue of securities

Part 7 - Details of proposed placement or other issue

only
	Part 7A - Conditions
		7A.1 Do any external approvals need to be obtained or other conditions satisfied before the placement or other
		type of issue can proceed on an unconditional basis?
			Yes
use	7A.1a Conditions
Approval/Condition	Date for determination	Is the date estimated or	** Approval
		+Security holder approval	7/4/2022			actual?	received/condition met?
				Estimated
								No
		Comments
personal
	P rt 7B - Issue details
			Is the proposed security a 'New		Will the proposed issue of this
			class' (+securities in a class that is		+security include an offer of
			not yet quoted or recorded by ASX)		attaching +securities?
			or an 'Existing class' (additional		No
			securities in a class that is already
			quoted or recorded by ASX)?
			New class
	Details of +securities proposed to be issued
For		ISIN Code (if Issuer is a foreign company and +securities are non CDIs)
	Have you received confirmation from		Will the entity be seeking quotation
			ASX that the terms of the proposed		of the 'new' class of +securities on
			+securities are appropriate and		ASX?
			equitable under listing rule 6.1?		No
			No
			ASX +security code			+Security description
			New class-code to be confirmed		Unlisted option exercisable at $0.005

+Security type Options

Proposed issue of securities

3 / 6

Proposed issue of securities

Number of +securities proposed to be issued 466,666,667

			Offer price details
only		Are the +securities proposed to be issued being issued for a cash consideration?
	No
			Please describe the consideration being provided for the +securities
			Nil consideration. The attaching options are being offered on a one for one basis to subscribers of the Placement
			announced 22 February 2022.
use		Please provide an estimate of the AUD equivalent of the consideration being
	provided for the +securities
0.0000001
			Will all the +securities issued in this class rank equally in all respects from
			their issue date?
personal		Yes
	Options details
			+Security currency	Exercise price	Expiry date
			AUD - Australian Dollar	AUD 0.0050	31/3/2024
			Details of the type of +security that will be issued if the option is exercised
			Other
			Description
			Unlisted options with a two year life and a $0.005 exercise price
			Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities
			proposed to be issued or provide the information by separate announcement.
For
	Part 7C - Timetable
		7C.1 Proposed +issue date
		7/4/2022
	Proposed issue of securities	4 / 6

Proposed issue of securities

Part 7D - Listing Rule requirements

7D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1?

	Yes
only	7D.1a Date of meeting or proposed meeting to approve the issue under listing rule 7.1
7/4/2022
	7D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue?
	No
use	7D.3 Will any of the +securities to be issued be +restricted securities for the purposes of the listing rules?
No

7D.4 Will any of the +securities to be issued be subject to +voluntary escrow? No

Part 7E - Fees and expenses

personal

7E.1 Will there be a lead manager or broker to the proposed issue? No

7E.2 Is the proposed issue to be underwritten? No

7E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed issue

6% fee paid to brokers to any placement funds raised.

Part 7F - Further Information

For

7F.01 The purpose(s) for which the entity is issuing the securities

Attaching option issued with placement shares, being used to raise funds to extend probiotic product range and working capital.

7F.1 Will the entity be changing its dividend/distribution policy if the proposed issue proceeds? No

7F.2 Any other information the entity wishes to provide about the proposed issue

Proposed issue of securities

5 / 6